JP2023553944A5 - - Google Patents
Info
- Publication number
- JP2023553944A5 JP2023553944A5 JP2023535390A JP2023535390A JP2023553944A5 JP 2023553944 A5 JP2023553944 A5 JP 2023553944A5 JP 2023535390 A JP2023535390 A JP 2023535390A JP 2023535390 A JP2023535390 A JP 2023535390A JP 2023553944 A5 JP2023553944 A5 JP 2023553944A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- registered trademark
- inflammatory
- composition according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200171340A KR20220081631A (ko) | 2020-12-09 | 2020-12-09 | 염증성 질환의 예방 및/또는 치료를 위한 피롤로-피리딘 유도체 화합물의 신규 용도 |
| KR10-2020-0171340 | 2020-12-09 | ||
| PCT/IB2021/000857 WO2022123311A1 (en) | 2020-12-09 | 2021-12-09 | Novel use of pyrrolopyridine derivatives for preventing or treating inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553944A JP2023553944A (ja) | 2023-12-26 |
| JP2023553944A5 true JP2023553944A5 (https=) | 2024-11-01 |
Family
ID=81974509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535390A Pending JP2023553944A (ja) | 2020-12-09 | 2021-12-09 | 炎症性疾患を予防または処置するためのピロロピリジン誘導体の新規な使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20220257605A1 (https=) |
| EP (1) | EP4259153A4 (https=) |
| JP (1) | JP2023553944A (https=) |
| KR (1) | KR20220081631A (https=) |
| CN (1) | CN116916929A (https=) |
| TW (1) | TW202239403A (https=) |
| WO (1) | WO2022123311A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3915985A4 (en) | 2019-01-18 | 2022-09-28 | Voronoi Co., Ltd. | PYRROLOPYRIDE DERIVATIVE AND USE THEREOF FOR THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASES |
| KR20220081631A (ko) | 2020-12-09 | 2022-06-16 | 보로노이 주식회사 | 염증성 질환의 예방 및/또는 치료를 위한 피롤로-피리딘 유도체 화합물의 신규 용도 |
| WO2023220396A1 (en) * | 2022-05-13 | 2023-11-16 | Fresh Tracks Therapeutics, Inc. | Methods of treatment using a dual specificity tyrosine-phosphorylation-regulated kinase 1a (dyrk1a) inhibitor |
| CN116270633A (zh) * | 2023-03-03 | 2023-06-23 | 神经肌肉骨骼再生医学中心有限公司 | 马拉韦罗在制备治疗肌肉退行性疾病的药物中的用途 |
| CN117244063A (zh) * | 2023-05-24 | 2023-12-19 | 中国人民解放军空军军医大学 | 核酸z-b变构诱导物用于制备治疗结石疾病药物的应用 |
| CN120754103B (zh) * | 2025-09-09 | 2025-11-28 | 苏州大学 | 阿巴卡韦在制备类风湿性关节炎治疗药物中的应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2354140A1 (en) | 2005-05-20 | 2011-08-10 | Vertex Pharmaceuticals Incorporated | Pyrrolopyridines useful as inhibitors of protein kinase |
| CN102127078A (zh) | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
| FR2912744B1 (fr) | 2007-02-16 | 2012-09-07 | Centre Nat Rech Scient | Composes pyrrolo°2,3-b!pyridine,composes azaindoles utiles dans la synthese de ces composes pyrrolo°2,3-b!pyridine, leurs procedes de fabrication et leurs utilisations. |
| AU2008296479A1 (en) | 2007-08-28 | 2009-03-12 | Dana Farber Cancer Institute | Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis |
| AU2009238590A1 (en) | 2008-04-22 | 2009-10-29 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
| MX353308B (es) | 2008-05-21 | 2018-01-08 | Ariad Pharma Inc | Derivados fosforosos como inhibidores de cinasa. |
| MY172424A (en) | 2009-04-03 | 2019-11-25 | Hoffmann La Roche | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof |
| CN102712601A (zh) * | 2009-11-12 | 2012-10-03 | 赛尔维他股份公司 | 化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂 |
| WO2011090738A2 (en) | 2009-12-29 | 2011-07-28 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| WO2012065935A1 (en) | 2010-11-17 | 2012-05-24 | F. Hoffmann-La Roche Ag | Methods of treating tumors |
| US8791112B2 (en) | 2011-03-30 | 2014-07-29 | Arrien Pharmaceuticals Llc | Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors |
| WO2013043232A2 (en) | 2011-04-08 | 2013-03-28 | Afraxis, Inc. | 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer |
| TW201533043A (zh) | 2013-04-18 | 2015-09-01 | Lundbeck & Co As H | 作爲ｌｒｒｋ２抑制劑的芳基吡咯并吡啶衍生化合物 |
| KR20160106623A (ko) | 2014-01-29 | 2016-09-12 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | 화합물 |
| RU2016134751A (ru) | 2014-01-29 | 2018-03-02 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | Соединения |
| MA39219B1 (fr) | 2014-01-29 | 2018-11-30 | Glaxosmithkline Ip Dev Ltd | Nouveaux composés inhibiteurs de la kinase lrrk2 utilisés pour le traitement du parkinson, de l’alzheimer et de la sclérose latérale amyotrophique |
| TN2017000329A1 (en) | 2015-01-28 | 2019-01-16 | Bayer Pharma AG | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| CN107801397B (zh) | 2015-02-13 | 2021-07-30 | 达纳－法伯癌症研究所公司 | Lrrk2抑制剂及其制备和使用方法 |
| JP6530826B2 (ja) | 2015-05-06 | 2019-06-12 | プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． | キナーゼを修飾する１ｈ−ピロロ［２，３−ｂ］ピリジン誘導体の合成 |
| TWI703150B (zh) | 2015-06-04 | 2020-09-01 | 美商庫拉腫瘤技術股份有限公司 | 用於抑制ｍｅｎｉｎ及ｍｌｌ蛋白之交互作用的方法及組合物 |
| CA3021021A1 (en) | 2016-04-15 | 2017-10-19 | Felicitex Therapeutics, Inc. | Combinations for the treatment of neoplasms using quiescent cell targeting and egfr inhibitors |
| EP3587422A4 (en) | 2017-02-22 | 2020-05-06 | Daegu-Gyeongbuk Medical Innovation Foundation | PYRROLOPYRIMIDINE DERIVATIVE COMPOUND, PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION WITH THIS COMPOUND AS AN ACTIVE SUBSTANCE FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE |
| CN110662745B (zh) | 2017-03-23 | 2021-08-03 | 大邱庆北尖端医疗产业振兴财团 | 吡咯并吡啶衍生物、其制备方法、和用于预防或治疗蛋白激酶相关疾病的药物组合物 |
| AU2020209789A1 (en) | 2019-01-18 | 2021-09-16 | Voronoi Co., Ltd. | Pyrrolopyrimidine derivative, and pharmaceutical composition for preventing or treating protein kinase-related disease comprising same as active ingredient |
| EP3915985A4 (en) * | 2019-01-18 | 2022-09-28 | Voronoi Co., Ltd. | PYRROLOPYRIDE DERIVATIVE AND USE THEREOF FOR THE PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISEASES |
| WO2020232332A1 (en) | 2019-05-16 | 2020-11-19 | Dana-Farber Cancer Institute, Inc. | Pyrrolopyrimidine inhibitors of wild-type and mutant forms of lrrk2 |
| WO2020235973A1 (ko) * | 2019-05-22 | 2020-11-26 | 주식회사 보로노이 | 암의 예방 및/또는 치료를 위한 피롤로-피리딘 유도체 화합물의 신규 용도 |
| KR20220081631A (ko) | 2020-12-09 | 2022-06-16 | 보로노이 주식회사 | 염증성 질환의 예방 및/또는 치료를 위한 피롤로-피리딘 유도체 화합물의 신규 용도 |
-
2020
- 2020-12-09 KR KR1020200171340A patent/KR20220081631A/ko active Pending
-
2021
- 2021-12-09 CN CN202180093340.1A patent/CN116916929A/zh not_active Withdrawn
- 2021-12-09 TW TW110146107A patent/TW202239403A/zh unknown
- 2021-12-09 WO PCT/IB2021/000857 patent/WO2022123311A1/en not_active Ceased
- 2021-12-09 EP EP21902773.7A patent/EP4259153A4/en active Pending
- 2021-12-09 US US17/643,554 patent/US20220257605A1/en not_active Abandoned
- 2021-12-09 JP JP2023535390A patent/JP2023553944A/ja active Pending
-
2023
- 2023-10-13 US US18/486,783 patent/US12194048B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023553944A5 (https=) | ||
| US12194048B2 (en) | Use of pyrrolopyridine derivatives for preventing or treating inflammatory diseases | |
| US12551564B2 (en) | IRAK degraders and uses thereof | |
| TWI868528B (zh) | Ｔｙｋ２抑制劑之生產方法 | |
| TW202144343A (zh) | Jak抑制劑化合物之結晶水合物 | |
| IL303458A (en) | IRAK joints and their uses | |
| CN107987075A (zh) | 用于治疗癌症和免疫性和自身免疫性疾病的细胞凋亡诱导剂 | |
| IL284125B1 (en) | History of quinoline use in the treatment of inflammatory diseases | |
| US20230416242A1 (en) | Double degraders and uses thereof | |
| US12162884B2 (en) | Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine as aryl hydrocarbon receptor (AHR) inhibitors | |
| EP3999185B1 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| US20250099454A1 (en) | Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a jak inhibitor | |
| TW202304902A (zh) | Jak抑制劑化合物之二鹽酸鹽之結晶形式 | |
| US20250170119A1 (en) | Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator | |
| US20250215002A1 (en) | Solid forms of tyk2 inhibitors and methods of use | |
| EP3999184B1 (en) | Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of sting | |
| US20250032474A1 (en) | Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator | |
| JP2025510859A (ja) | Ｔｙｋ２阻害剤製剤及びその作製方法 | |
| CN120737203A (zh) | 抗cd38蛋白抗体及其制备方法和应用 | |
| WO2025147509A1 (en) | Stat6 inhibitors and uses thereof | |
| TW202529769A (zh) | Ｔｙｋ２抑制劑及其用途 |